AKT1 and melanoma: SiRNA transfection targeting AKT3 or overexpression of PTEN can effectively suppress AKT3 activity to reduce the tumorigenic potential of melanoma cells.42 Therefore, the hyper-activation of AKT pathway is a pivotal oncogenic event for melanoma carcinogenesis and development.